Black Dots in Trichoscopy After COVID-19: Can It Be Telogen Effluvium?

    July 2021 in “ Dermatologic Therapy ”
    Maria Vastarella, Mariateresa Cantelli, Paola Nappa … Sonia Sofía Ocampo‐Garza
    Studysummary This case study reports a 58-year-old woman experiencing pressure-induced alopecia with concomitant acute telogen effluvium after severe COVID-19, suggesting a potential link between prolonged hospitalization and hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients Experimental Dermatology · 2021
    2. Telogen Effluvium in the New SARS-CoV-2 Era International Journal of Dermatology · 2021
    3. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021

    Related research 6

    1. Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss Journal of The American Academy of Dermatology · 2022
    2. Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss Dermatology Reports · 2022
    3. Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata JAAD case reports · 2021
    4. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    5. Topical and Intralesional Therapies for Alopecia Areata Dermatologic therapy · 2011
    6. Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases Dermatologic Therapy · 2011